BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221003
DTEND;VALUE=DATE:20221006
DTSTAMP:20260516T041220
CREATED:20220623T103213Z
LAST-MODIFIED:20220623T103213Z
UID:34498-1664755200-1665014399@www.pharmajournalist.com
SUMMARY:LEAP TA: Life Sciences 2022
DESCRIPTION:The Definitive Event to Transform Your Internal Impact & Differentiate Your Employer Brand to Attract the in-Demand Biopharma Talent Required to Fast-Track Business Innovation & Growth \nNow in its fourth year\, LEAP TA: Life Sciences is the only forum dedicated to helping established and emerging life sciences organizations operating in the US who are breaking away from traditional TA to develop high functioning TA teams bursting to inspire talent needed to drive mission-critical innovation. \nIt is a unique opportunity to engage in a genuinely disruptive dialogue with your peers around what TA tech tools are really worth the investment and the radical new talent acquisition strategies required to address how life sciences organizations will deal with the fallout of the tight talent market in 2022 and beyond. \nDesigned for anyone with a stake in talent acquisition at the heart of biopharma businesses of all sizes\, those who take part will find out how to rewrite the rules of talent acquisition to balance speed with fit in finding brilliant people to gain a sustainable competitive advantage. \nSo\, whether you work in the newest start-up biotech or the largest big pharma company\, there’s something at this event for you. Secure your place now to save time\, money and add vital efficiencies to your talent acquisition activities. \nTo know more visit: https://bit.ly/3HO1Tdv
URL:https://www.pharmajournalist.com/event/leap-ta-life-sciences-2022/
LOCATION:Embassy Suites by Hilton Boston at Logan Airport\, 207 Porter St\, Boston\, MA\, 02128\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221004
DTEND;VALUE=DATE:20221007
DTSTAMP:20260516T041220
CREATED:20220610T091530Z
LAST-MODIFIED:20220610T091530Z
UID:34394-1664841600-1665100799@www.pharmajournalist.com
SUMMARY:2nd Rare and Genetic Kidney Drug Development Summit
DESCRIPTION:Uniting industry experts dedicated to accelerating the frontier of transformative therapeutics\, the 2nd Rare & Genetic Kidney Disease Drug Development Summit is the definitive industry forum sharing cross-industry insight to understand genetic drivers of disease\, uncover early biomarkers of efficacy\, and navigate disease specific endpoint development. \nFrom clarifying molecular characteristics to reclassify disease subtypes to enrolling patient cohorts in rare disease populations\, join industry experts in-person from Travere Therapeutics\, FDA\, Sanofi\, Chinook Therapeutics\, Goldfinch Bio\, Takeda\, Regulus Therapeutics\, Otsuka and many more to accelerate life-changing therapeutics for the treatment of ADPKD\, ARPKD\, IgA\, FSGS\, Alport Syndrome. \nTo know more visit: https://ter.li/rzowfh
URL:https://www.pharmajournalist.com/event/2nd-rare-and-genetic-kidney-drug-development-summit/
LOCATION:Hilton Woburn\, 2 Forbes Road\, Woburn\, MA\, 01801\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:(+1) 617 455 4188
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221004
DTEND;VALUE=DATE:20221007
DTSTAMP:20260516T041220
CREATED:20220630T094848Z
LAST-MODIFIED:20220630T094848Z
UID:34555-1664841600-1665100799@www.pharmajournalist.com
SUMMARY:4th Macrophage-directed Therapies Summit
DESCRIPTION:4th Macrophage-directed Therapies Summit\, taking place from 4-6 of October in Boston\, will bring together professionals to accelerate the clinical validation of macrophage-directed therapies\, manipulating and fixing phenotypic plasticity to develop safe\, targeted therapies for oncology\, autoimmunity\, inflammation and beyond. \nJoin your peers in person and delve into: \n\nCD47 targeting and other ‘don’t eat me’ signals\nSafety concerns due to model translatability and dosing\nOptimal combination or monotherapy discovery\n\nYou can view the event guide here: https://ter.li/ezyi0h \nSecure your place at the summit here: https://ter.li/x9p0ua \nWe are looking forward to welcoming you to Boston this October!
URL:https://www.pharmajournalist.com/event/4th-macrophage-directed-therapies-summit/
LOCATION:Crowne Plaza Boston Woburn\, 15 Middlesex Canal Park Dr\, Woburn\, MA\, 01801\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20221005
DTEND;VALUE=DATE:20221007
DTSTAMP:20260516T041220
CREATED:20220630T101923Z
LAST-MODIFIED:20220630T102012Z
UID:34567-1664928000-1665100799@www.pharmajournalist.com
SUMMARY:2nd Annual Next Generation Pharmaceutical Cleanroom
DESCRIPTION:2nd Annual Next Generation Pharmaceutical Cleanroom \n5 – 6 October 2022\nLondon\, UK\nhttp://www.nextgen-pharmacleanroom.com/PJwl \nSponsored by Ecolab\, Elis Cleanroom\, Innerspace\, Microgenetics\, Novatek \nCo-Chaired by: Conor Murray\, Chairman\, Irish Cleanroom Society and Connor McMorrow\, Aseptic Lead Cell Therapy\, Takeda  \nAdvances in Pharma 4.0 for an Improved\, Efficient and Contaminant-Free Cleanroom \nSAE Media Group are pleased to announce the 2nd Annual Next Generation Pharmaceutical Cleanroom Conference. An event that focuses on cleanroom technology in the pharmaceutical industry\, the conference will serve to bridge that gap between the two areas while simultaneously providing a unique selling point. \nThis one-of-a-kind meeting will facilitate networking opportunities with key opinion leaders from all areas of pharmaceuticals\, biologicals\, and cleanroom industry experts to explore hot topics within cleanroom design and engineering\, best practices and regulation\, environmental and contamination control\, and pharmaceutical microbiology. \nIn 2025\, the global cleanroom technology market is expected to reach nearly $5 billion. Stringent regulatory standards for product approvals\, technological advancements in cleanrooms\, initiatives taken by private organisations to create awareness regarding cleanroom and growth of the healthcare sector globally are among the few factors expected to drive the market. \nThis event will look in-depth at the significant change that the cleanroom industry is going through. From the new operating practices that keep the product as sterile as possible\, to the developments in technology that are enabling this to happen. Whether through robotics\, automated disinfection\, or data driven environmental monitoring- this conference will highlight the developments that are fundamentally changing the industry. \nEvent Hashtag: #PharmaCleanrooms \nKey Reasons to attend: \n\nLearn how to maximise the latest cleanroom technologies to modernise your contamination control strategy\nMaximise the cost-effectiveness of your cleanroom and navigate best practises for cleanroom design\nOptimise your preparation for upcoming regulatory changes\, including the impending Annex 1\nIncrease your cleanroom availability & accessibility through streamlined approaches to contamination control\n\nWHO SHOULD ATTEND: \nSenior Micro Manager\, QC Manager\, Quality Director\, Clean Room Design Managers\, Design\, Qualify and Testing – Clean Room (across the board)\, Head of Clean Room Technologies\, Head of Compounding Pharmacies\, Head of Clinical Drug Products\, Head of Clinical Medical Device \nView the brochure and to download visit http://www.nextgen-pharmacleanroom.com/PJwl
URL:https://www.pharmajournalist.com/event/2nd-annual-next-generation-pharmaceutical-cleanroom/
LOCATION:Copthorne Tara Hotel\, Scarsdale Place\, Kensington\, London\, W8 5SY\, United Kingdom
ORGANIZER;CN="SAE Media Group":MAILTO:ssapal@smi-online.co.uk
END:VEVENT
END:VCALENDAR